BECTON DICKINSON & CO — Director's Dealing 2022

Aug 17, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2022-08-15

Reporting Person: Hickey David (EVP & President, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-08-15	Common Stock	S	475	$265.00	Disposed	3331	Direct

Footnotes

F1: Direct holdings reflect adjustments made in connection with the spin-off of Embecta Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. This transaction was made pursuant to a 10b5-1 plan entered into on March 9, 2022.